Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Bachmann

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
NPJ Vaccines|August 25, 2021
Neutralization of MERS coronavirus through a scalable nanoparticle vaccineMona O Mohsen, Dominik Rothen, Ina Balke, et al.
Vaccines|July 2, 2021
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle DeliveryDavid Peterhoff, Stefanie Thalhauser, Jan M Sobczak, et al.
Frontiers in Immunology|December 16, 2020
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT<sup>®</sup>)Matthew D Heath, Mona O Mohsen, Pieter-Jan de Kam, et al.
Plos One|June 26, 2008
A vaccine against nicotine for smoking cessation: a randomized controlled trialJacques Cornuz, Susanne Zwahlen, Walter Felix Jungi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cellsCaroline E von Allmen, Nicole Schmitz, Monika Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosisGunther Spohn, Reto Guler, Pål Johansen, et al.
European Journal of Immunology|December 21, 2012
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosisAlain C Tissot, Gunther Spohn, Gary T Jennings, et al.
Vaccines|September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and SpecificityDominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
Vaccines|May 14, 2020
Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in HorsesSigridur Jonsdottir, Victoria Fettelschoss, Florian Olomski, et al.
Vaccines|June 27, 2024
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus ResponseJan M Sobczak, Irena Barkovska, Ina Balke, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
NPJ Vaccines|August 25, 2021
Neutralization of MERS coronavirus through a scalable nanoparticle vaccineMona O Mohsen, Dominik Rothen, Ina Balke, et al.
Vaccines|July 2, 2021
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle DeliveryDavid Peterhoff, Stefanie Thalhauser, Jan M Sobczak, et al.
Frontiers in Immunology|December 16, 2020
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT<sup>®</sup>)Matthew D Heath, Mona O Mohsen, Pieter-Jan de Kam, et al.
Plos One|June 26, 2008
A vaccine against nicotine for smoking cessation: a randomized controlled trialJacques Cornuz, Susanne Zwahlen, Walter Felix Jungi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2009
Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cellsCaroline E von Allmen, Nicole Schmitz, Monika Bauer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosisGunther Spohn, Reto Guler, Pål Johansen, et al.
European Journal of Immunology|December 21, 2012
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosisAlain C Tissot, Gunther Spohn, Gary T Jennings, et al.
Vaccines|September 27, 2025
Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and SpecificityDominik A Rothen, Alessandro Pardini, Sudip Kumar Dutta, et al.
Vaccines|May 14, 2020
Safety Profile of a Virus-Like Particle-Based Vaccine Targeting Self-Protein Interleukin-5 in HorsesSigridur Jonsdottir, Victoria Fettelschoss, Florian Olomski, et al.
Vaccines|June 27, 2024
Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus ResponseJan M Sobczak, Irena Barkovska, Ina Balke, et al.
Pageof 25